Bradley Foster & Sargent’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-6,151
| Closed | -$223K | – | 355 |
|
|
2016
Q4 | $223K | Buy |
6,151
+1,401
| +29% | +$50.8K | 0.01% | 327 |
|
|
2016
Q3 | $219K | Hold |
4,750
| – | – | 0.01% | 321 |
|
|
2016
Q2 | $239K | Buy |
4,750
+100
| +2% | +$5.03K | 0.01% | 304 |
|
|
2016
Q1 | $249K | Hold |
4,650
| – | – | 0.01% | 296 |
|
|
2015
Q4 | $305K | Sell |
4,650
-753
| -14% | -$49.4K | 0.01% | 276 |
|
|
2015
Q3 | $305K | Hold |
5,403
| – | – | 0.02% | 285 |
|
|
2015
Q2 | $319K | Hold |
5,403
| – | – | 0.01% | 297 |
|
|
2015
Q1 | $337K | Buy |
5,403
+195
| +4% | +$12.2K | 0.02% | 294 |
|
|
2014
Q4 | $300K | Sell |
5,208
-500
| -9% | -$28.8K | 0.01% | 290 |
|
|
2014
Q3 | $307K | Buy |
5,708
+563
| +11% | +$30.3K | 0.01% | 298 |
|
|
2014
Q2 | $270K | Buy |
+5,145
| New | +$270K | 0.01% | 304 |
|
|
2014
Q1 | – | Sell |
-37,580
| Closed | -$1.51M | – | 350 |
|
|
2013
Q4 | $1.51M | Sell |
37,580
-1,754
| -4% | -$70.3K | 0.08% | 162 |
|
|
2013
Q3 | $1.49M | Buy |
39,334
+338
| +0.9% | +$12.8K | 0.09% | 150 |
|
|
2013
Q2 | $1.53M | Buy |
+38,996
| New | +$1.53M | 0.09% | 141 |
|